42 stories from 15 sources
Supporting Articles
Anthony Fauci invoked the Fifth Amendment during a Senate hearing as Republican lawmakers questioned him about his role in the COVID-19 response. The amendment protects witnesses from being compelled to give answers that could be self-incriminating.
11:04 PMAl JazeeraRobert F. Kennedy Jr. said he found Anthony Fauci's diary in government archives as Fauci repeatedly invoked the Fifth Amendment during questioning about COVID-19's origins. Rand Paul's panel plans to vote next week on whether to hold Fauci in contempt for refusing to answer.
5:27 PMFortuneThe Trump administration cut U.S. funding for Gavi, the global vaccine alliance, amid its broader conflict with the World Health Organization and related United Nations health institutions. The decision threatens a major source of support for international immunization programs.
8:26 PMAl Jazeera
Medicare Advantage plans could gain enrollment if the administration ends a program that has helped hold down premiums for Medicare Part D prescription drug plans. Higher Part D costs may push beneficiaries to compare alternatives more aggressively.
2:06 PMMarketWatch
The White House decision to end a Medicare drug subsidy is poised to increase out-of-pocket costs for some beneficiaries and gives Democrats a new line of attack on prescription affordability ahead of midterms. The change reshapes messaging around who is responsible for higher drug bills.
10:58 AMStat News
Medicare is changing a prescription drug program that helped keep premiums down. Analysts expect the shift to raise premiums for some beneficiaries and accelerate movement into Medicare Advantage plans.
11:29 AMMarketWatchThe FTC sued Hims and Hers over alleged sharing of health data with Meta and Snap, as well as billing practices and subscription cancellations. The company’s shares fell 10% after the action.
4:30 PMCNBC
The FTC sued Hims and Hers, alleging that the telehealth company misled consumers and violated their privacy. The case adds federal enforcement pressure to the company’s marketing and data practices.
2:45 PMStat News
A Rutgers led survey in the Newark area found unusually high rates of cognitive decline among older residents, many in public or subsidized housing. Researchers warn the findings point to an emerging dementia burden that local systems are not prepared to manage.
10:34 AMGothamistShareholders allege Novo Nordisk misled investors about the tolerability profile of CagriSema, after clinical trial results disappointed and the company’s market value fell sharply. The lawsuit centers on whether disclosures about side effects and patient dropouts matched what the company knew.
10:59 AMCNBCHospitals are moving from testing whether AI works to confronting who is liable when AI-driven tools fail across clinical decision support, patient communications, and administrative workflows. The piece argues that responsibility cannot be shifted to vendors as AI becomes embedded in care delivery and operations.
4:00 AMPYMNTS
A large U.S. trial found that silver diamine fluoride, applied as a quick liquid, stopped decay in more than half of treated baby teeth without drilling, anesthesia, or sedation. The tradeoff is permanent dark staining of the decayed area.
8:35 AMScienceDailySummary
Anthony Fauci invoked the Fifth Amendment during a Senate hearing as Republican lawmakers questioned him about his role in the COVID-19 response. The amendment protects witnesses from being compelled to give answers that could be self-incriminating.
Fauci's refusal to answer specific questions shifts the hearing from policy scrutiny toward possible legal
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The invocation raises the legal stakes around pandemic decisions while leaving the underlying factual disputes unresolved.
5 stories · 4 sources
Summary
Robert F. Kennedy Jr. said he found Anthony Fauci's diary in government archives as Fauci repeatedly invoked the Fifth Amendment during questioning about COVID-19's origins. Rand Paul's panel plans to vote next week on whether to hold Fauci in contempt for refusing to answer.
The next decisive step is the contempt vote, which could turn the dispute into a
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The contempt vote could determine whether the COVID-origins investigation gains enforcement power or remains a partisan inquiry.
Summary
The Trump administration cut U.S. funding for Gavi, the global vaccine alliance, amid its broader conflict with the World Health Organization and related United Nations health institutions. The decision threatens a major source of support for international immunization programs.
The funding cutoff shifts the immediate burden of vaccine financing onto Gavi and other donors,
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A funding gap in Gavi's programs could reduce childhood vaccination coverage and increase the risk of preventable outbreaks.
Summary
Medicare Advantage plans could gain enrollment if the administration ends a program that has helped hold down premiums for Medicare Part D prescription drug plans. Higher Part D costs may push beneficiaries to compare alternatives more aggressively.
Ending the subsidy program would make stand-alone prescription coverage less attractive for some Medicare beneficiaries.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A prescription-drug policy change could accelerate the shift from traditional Medicare toward privately administered Medicare Advantage plans.
Summary
The White House decision to end a Medicare drug subsidy is poised to increase out-of-pocket costs for some beneficiaries and gives Democrats a new line of attack on prescription affordability ahead of midterms. The change reshapes messaging around who is responsible for higher drug bills.
Ending the subsidy shifts immediate cost exposure onto seniors, even if the policy rationale is
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Prescription costs are a top voter concern, and Medicare changes can move both turnout and persuasion.
Summary
Medicare is changing a prescription drug program that helped keep premiums down. Analysts expect the shift to raise premiums for some beneficiaries and accelerate movement into Medicare Advantage plans.
Premium stabilization is weakening as Medicare rewires the mechanism that spread drug costs across plans.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Small program design changes in Part D can quickly reshape premiums, plan competition, and where seniors get coverage.
Summary
The FTC sued Hims and Hers over alleged sharing of health data with Meta and Snap, as well as billing practices and subscription cancellations. The company’s shares fell 10% after the action.
The lawsuit turns Hims and Hers’ growth model into a regulatory liability, with scrutiny focused
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Telehealth companies could face broader enforcement if regulators treat targeted advertising and difficult cancellations as consumer-protection violations.
Summary
The FTC sued Hims and Hers, alleging that the telehealth company misled consumers and violated their privacy. The case adds federal enforcement pressure to the company’s marketing and data practices.
The allegations put the company’s customer-acquisition strategy under direct scrutiny, particularly how it represents services
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The case tests how aggressively regulators will police privacy and marketing claims in direct-to-consumer telehealth.
Summary
A Rutgers led survey in the Newark area found unusually high rates of cognitive decline among older residents, many in public or subsidized housing. Researchers warn the findings point to an emerging dementia burden that local systems are not prepared to manage.
The decisive shift is evidence of potentially concentrated dementia prevalence in a high need urban
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
If dementia is clustering in under resourced communities, local health systems will face a cost and capacity shock with few near term clinical fixes.
Summary
Shareholders allege Novo Nordisk misled investors about the tolerability profile of CagriSema, after clinical trial results disappointed and the company’s market value fell sharply. The lawsuit centers on whether disclosures about side effects and patient dropouts matched what the company knew.
The tolerance and persistence bar for obesity drugs is rising as competition tightens. Novo is
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Obesity drug valuations and adoption hinge on tolerability, and legal pressure can reshape how companies report and market trial outcomes.
Summary
Hospitals are moving from testing whether AI works to confronting who is liable when AI-driven tools fail across clinical decision support, patient communications, and administrative workflows. The piece argues that responsibility cannot be shifted to vendors as AI becomes embedded in care delivery and operations.
Accountability is shifting from experimentation to enforceable responsibility as AI enters higher-stakes clinical use. Health
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Hospitals that treat AI as a plug-in service risk absorbing patient-safety failures and regulatory exposure without the controls to prevent them.
Summary
A large U.S. trial found that silver diamine fluoride, applied as a quick liquid, stopped decay in more than half of treated baby teeth without drilling, anesthesia, or sedation. The tradeoff is permanent dark staining of the decayed area.
Caries treatment can shift from surgical workflows to office or community-based application. Young children, especially
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A low-friction, low-cost intervention could reduce pain, infections, and operating-room dental procedures for kids.
A curated list of other prominent stories from this day.
Teva Pharmaceuticals CEO Richard Francis discussed the company’s positive second-quarter earnings, its drug pipeline, the expected effects of changing Medicare rules on patients, and Teva’s new direct listing on the New York Stock Exchange.
7:55 PMBloomberg MarketsNew York City sued two Brooklyn dental practices, alleging that they steered patients toward high-interest loans and falsely claimed that some procedures were not covered by insurance.
11:08 AMNYT New York
A preliminary study found that older adults taking a daily multivitamin reported better functional health after three years than those taking a placebo. The findings have not yet undergone peer review.
7:44 PMScienceDailyThe article revisits a scientific literature review and meta-analysis on COVID-19 lockdowns conducted by the author and two colleagues. It argues that Fauci did not adequately engage with their conclusions.
6:17 PMFortuneAttovia Therapeutics, an early-stage biotech developing treatments for immune-mediated diseases, is seeking to raise up to $212.5 million through a US initial public offering.
5:53 PMBloomberg MarketsNewly released pages from Anthony Fauci’s pandemic diary describe President Donald Trump’s temperature reaching 103°F and his struggle to breathe, prompting Mark Meadows to seek Fauci’s advice about Trump’s return to public life. The diary also includes Fauci’s account of meeting actress Julia Roberts.
5:47 PMFortune
Latigo Biotherapeutics reported positive mid-stage results for an acute-pain drug designed to compete with Vertex’s Journavx. The data support further development of another non-opioid treatment option.
5:00 PMStat News
New York City officials say publicizing noncompliant buildings on the Upper East Side helped spur testing for Legionella, the bacteria linked to Legionnaires’ disease. The approach shows how officials are pressing building owners to follow disease-prevention measures.
3:29 PMGothamistHumana beat quarterly expectations and kept its 2026 adjusted profit outlook at at least $9 per share, citing medical costs that remain within its assumptions. Some investors expected an upward revision and reacted to the unchanged guidance as underwhelming.
12:18 PMCNBCHumana held its annual profit guidance despite a strong second quarter, weighing on the insurer's shares. P&G offered a cautious fiscal-year outlook after quarterly results missed estimates, while Kering rallied on better-than-expected Gucci revenue.
11:17 AMBloomberg MarketsThe piece argues patients should not immediately pay surprise medical bills and should first verify charges, coding, and insurance adjudication. It lays out steps to request itemized bills, compare explanations of benefits, and negotiate or dispute errors.
11:07 AMMarketWatch
Vital Infrastructure Property Trust bought the 142,249-square-foot East New York Health Hub at 101 Pennsylvania Avenue in Brooklyn for $89.9 million. The property is leased as an outpatient facility to AdvantageCare Physicians.
10:59 AMHousing WireMichael J. Fox will receive the Television Academy’s Bob Hope Humanitarian Award at this year’s Emmys for his work advancing Parkinson’s disease research and advocacy. The honor adds a major philanthropic recognition to his long-standing television legacy.
9:00 AMVarietyPractical steps like limiting indoor heat gain, timing ventilation for cooler outdoor air, and using lighter bedding and fans can improve sleep during heatwaves. The guidance emphasizes preventing the home from overheating and using cooling strategies safely.
1:35 AMScienceDailySummary
Teva Pharmaceuticals CEO Richard Francis discussed the company’s positive second-quarter earnings, its drug pipeline, the expected effects of changing Medicare rules on patients, and Teva’s new direct listing on the New York Stock Exchange.
Teva is pairing stronger recent performance with a market-access shift and a higher-profile US listing.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Teva’s outlook now depends on both drug development and how Medicare policy reshapes its commercial market.
Summary
New York City sued two Brooklyn dental practices, alleging that they steered patients toward high-interest loans and falsely claimed that some procedures were not covered by insurance.
The alleged scheme targeted patients facing urgent dental care who had limited ability to challenge
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The lawsuit tests whether dental practices can use medical urgency and confusing payment terms to push patients into costly debt.
Summary
A preliminary study found that older adults taking a daily multivitamin reported better functional health after three years than those taking a placebo. The findings have not yet undergone peer review.
The reported benefit concerns everyday function, not proof that multivitamins prevent disability or extend life.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A low-cost intervention could have broad implications for healthy aging, but the evidence is not yet strong enough to support a policy shift.
Summary
The article revisits a scientific literature review and meta-analysis on COVID-19 lockdowns conducted by the author and two colleagues. It argues that Fauci did not adequately engage with their conclusions.
The central dispute is over how policymakers weighed evidence on lockdown effectiveness and harms during
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The debate affects how governments balance disease control, economic disruption, and civil liberties in the next public-health emergency.
Summary
Attovia Therapeutics, an early-stage biotech developing treatments for immune-mediated diseases, is seeking to raise up to $212.5 million through a US initial public offering.
Attovia’s proposed IPO tests investor appetite for high-risk biotech assets despite the company’s early development
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The offering will show whether public markets are again willing to finance speculative drug developers at scale.
Summary
Newly released pages from Anthony Fauci’s pandemic diary describe President Donald Trump’s temperature reaching 103°F and his struggle to breathe, prompting Mark Meadows to seek Fauci’s advice about Trump’s return to public life. The diary also includes Fauci’s account of meeting actress Julia Roberts.
The records add detail to how serious Trump’s illness was and show Fauci advising the
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The diary provides a contemporaneous record of the medical and political pressure surrounding Trump’s Covid treatment.
Summary
Latigo Biotherapeutics reported positive mid-stage results for an acute-pain drug designed to compete with Vertex’s Journavx. The data support further development of another non-opioid treatment option.
The results strengthen competition in a market seeking alternatives to opioids, but they do not
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A successful rival could expand non-opioid pain treatment and pressure Vertex on pricing and market share.
Summary
New York City officials say publicizing noncompliant buildings on the Upper East Side helped spur testing for Legionella, the bacteria linked to Legionnaires’ disease. The approach shows how officials are pressing building owners to follow disease-prevention measures.
Public disclosure has become a practical enforcement tool where voluntary compliance falls short. The city’s
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Preventing Legionnaires’ disease depends on reaching private building owners before contaminated systems create an outbreak.
Summary
Humana beat quarterly expectations and kept its 2026 adjusted profit outlook at at least $9 per share, citing medical costs that remain within its assumptions. Some investors expected an upward revision and reacted to the unchanged guidance as underwhelming.
The key signal is cost trend stability, not upside surprise. Medicare Advantage economics hinge on
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Insurer profitability affects Medicare Advantage benefits, premiums, and how aggressively plans manage care.
Summary
Humana held its annual profit guidance despite a strong second quarter, weighing on the insurer's shares. P&G offered a cautious fiscal-year outlook after quarterly results missed estimates, while Kering rallied on better-than-expected Gucci revenue.
The market is rewarding evidence of stabilization at Gucci while penalizing cautious guidance and earnings
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Guidance and brand-level performance are driving fashion and consumer-stock valuations more than headline quarterly revenue.
Summary
The piece argues patients should not immediately pay surprise medical bills and should first verify charges, coding, and insurance adjudication. It lays out steps to request itemized bills, compare explanations of benefits, and negotiate or dispute errors.
The decisive shift is treating medical bills as negotiable and frequently incorrect, not as final
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Small process steps can prevent unnecessary out-of-pocket spending and expose systemic billing errors at scale.
Summary
Vital Infrastructure Property Trust bought the 142,249-square-foot East New York Health Hub at 101 Pennsylvania Avenue in Brooklyn for $89.9 million. The property is leased as an outpatient facility to AdvantageCare Physicians.
Institutional capital is moving deeper into outpatient real estate tied to long-term leases. That shifts
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Ownership changes in outpatient facilities can reshape clinic economics and stability for providers and patients in a high-need neighborhood.
Summary
Michael J. Fox will receive the Television Academy’s Bob Hope Humanitarian Award at this year’s Emmys for his work advancing Parkinson’s disease research and advocacy. The honor adds a major philanthropic recognition to his long-standing television legacy.
The Television Academy is using a prime, widely viewed platform to elevate Fox’s Parkinson’s work
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A major Emmy-stage humanitarian honor can translate celebrity recognition into real-world funding and momentum for disease research.
Summary
Practical steps like limiting indoor heat gain, timing ventilation for cooler outdoor air, and using lighter bedding and fans can improve sleep during heatwaves. The guidance emphasizes preventing the home from overheating and using cooling strategies safely.
Hot nights are becoming a recurrent health stressor, not an occasional inconvenience. Poor sleep compounds
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Sleep disruption is a common and preventable pathway from heat exposure to real health harm.
Make it yours
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!